Psychiatric Manifestations in Patients with Biopterin Defects

Area of Science:

• Neuroscience
• Metabolic Disorders
• Psychiatry

Background:

• Tetrahydrobiopterin (BH4) defects are rare metabolic disorders.
• Psychiatric manifestations are frequent in BH4 deficiency, linked to neurotransmitter abnormalities.
• Neurotransmitters like dopamine, serotonin, and norepinephrine are often affected.

Purpose of the Study:

• To review the psychiatric profile of patients with BH4 defects.
• To describe behavioral disturbances and comorbidities in BH4 deficiency.
• To highlight challenges in managing psychiatric symptoms in these patients.

Main Methods:

• Retrospective review of patients with BH4 defects.
• Analysis of psychiatric profiles in pediatric and adult metabolic clinics.
• Inclusion of patients with guanosine triphosphate cyclohydrolase (GTPCH) and 6-pyruvoyl tetrahydropterin synthase (PTPS) deficiencies.

Main Results:

• All reviewed patients exhibited behavioral disturbances.
• Two patients presented with significant psychiatric comorbidities, including ADHD, anxiety, and depression.
• Severe psychiatric presentations required intensive treatment and behavioral therapy.

Conclusions:

• Psychiatric manifestations in BH4 defects are common and challenging to manage.
• Lack of information hinders effective treatment strategies for psychiatric symptoms.
• Further research is needed to establish the safety and efficacy of psychiatric medications in BH4 deficiency.